510(k) K223101

BD Secondary Infusion Set by Care Fusion — Product Code FPA

K223101 is an FDA 510(k) premarket notification submitted by Care Fusion for the device "BD Secondary Infusion Set". The FDA issued a decision of Substantially Equivalent on May 12, 2023. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Care Fusion has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 12, 2023
Date Received
September 30, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Set, Administration, Intravascular
Device Class
Class II
Regulation Number
880.5440
Review Panel
HO
Submission Type